SNYR vs MNMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MNMD Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mind Medicine (MindMed) Inc. Common Shares (MNMD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNYR counters with relative strength in Valuation. Fundamentally, SNYR trades at 0.6x Forward P/E with -10.3% operating margin (-32.8% YoY revenue) versus MNMD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MNMD sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SNYR | MNMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.1M | $1.4B | Larger Scale | MNMD |
| Trailing P/E Ratio Valuation | 0.6x | N/M | Lower Multiple | SNYR |
| Forward P/E Ratio Valuation | 0.6x | N/M | Lower Multiple | SNYR |
| Revenue Growth (YoY) Growth | -32.8% | +0.0% | Higher Growth | MNMD |
| Operating Margin (TTM) Profitability | -10.3% | 0.0% | Higher Margin | MNMD |
| Net Profit Margin Profitability | -57.0% | 0.0% | Higher Margin | MNMD |
| Return on Equity (ROE) Capital Efficiency | -361.1% | -85.6% | Higher ROE | MNMD |
| 52-Week Range Position Momentum | 1% ($0โ$3) | 98% ($5โ$15) | Stronger Trend | MNMD |
| Beta / 30D Volatility Risk Regime | -0.86ฮฒ ยท 868% Vol | 1.79ฮฒ ยท 55% Vol | Lower Realized Risk | MNMD |
| Unified Institutional Score Composite Signal | 48.9 / 100 (HOLD) | 63.1 / 100 (BUY) | Higher Composite | MNMD |